TY - STD TI - Alzheimer’s Disease International. World Alzheimer’s Report 2010. The Global Economic Impact of Dementia. London: Alzheimer’s Disease International; 2010. ID - ref1 ER - TY - JOUR AU - Malouf, R. AU - Birks, J. PY - 2004 DA - 2004// TI - Donepezil for vascular cognitive impairment JO - Cochrane Database Syst Rev VL - 1 ID - Malouf2004 ER - TY - JOUR AU - Román, G. C. PY - 2002 DA - 2002// TI - Vascular dementia may be the most common form of dementia in the elderly JO - J Neurol Sci VL - 203–204 UR - https://doi.org/10.1016/S0022-510X(02)00252-6 DO - 10.1016/S0022-510X(02)00252-6 ID - Román2002 ER - TY - STD TI - O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. Lancet Neurol. 2003;2:89–98. ID - ref4 ER - TY - JOUR AU - Tarvonen-Schröder, S. AU - Röyttä, M. AU - Räihä, I. AU - Kurki, T. AU - Rajala, T. AU - Sourander, L. PY - 1996 DA - 1996// TI - Clinical features of leuko-araiosis JO - J Neurol Neurosurg Psychiatry VL - 60 UR - https://doi.org/10.1136/jnnp.60.4.431 DO - 10.1136/jnnp.60.4.431 ID - Tarvonen-Schröder1996 ER - TY - JOUR AU - Greenberg, S. M. PY - 2006 DA - 2006// TI - Small vessels, big problems JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMp068043 DO - 10.1056/NEJMp068043 ID - Greenberg2006 ER - TY - JOUR AU - Lopez-Arrieta, J. AU - Birks, J. PY - 2009 DA - 2009// TI - Nimodipine for primary degenerative, mixed and vascular dementia JO - Cochrane Database Syst Rev VL - 3 ID - Lopez-Arrieta2009 ER - TY - STD TI - Dorn M. Effect of nimodipine on the wellbeing, symptoms and efficacy of ambulatory patients with cerebrovascular disorders. In: Betz E, Deck K, Hoffmeister F, editors. Nimodipine. Pharmacological and clinical properties, Proceedings of the First International Symposium. New York: Stuttgart; 1985. p. 295–304. ID - ref8 ER - TY - STD TI - Fischhof PK, Wagner G, Littschauer L, Rüther E, Apecechea M, Hiersemenzel R, Röhmel J, Hoffmeister F, Schmage N. Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In: Bergener M, Reisberg B, editors. Diagnosis and treatment of senile dementia. New York: Springer; 1989. p. 350–9. ID - ref9 ER - TY - STD TI - Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, Wallin A. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 2000;175:124–34. ID - ref10 ER - TY - STD TI - Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–31. ID - ref11 ER - TY - STD TI - Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895–906. ID - ref12 ER - TY - JOUR AU - Wang, J. G. AU - Li, Y. AU - Franklin, S. S. AU - Safar, M. PY - 2007 DA - 2007// TI - Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview JO - Hypertension VL - 50 UR - https://doi.org/10.1161/HYPERTENSIONAHA.107.089763 DO - 10.1161/HYPERTENSIONAHA.107.089763 ID - Wang2007 ER - TY - JOUR AU - Law, M. R. AU - Morris, J. K. AU - Wald, N. J. PY - 2009 DA - 2009// TI - Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies JO - BMJ VL - 338 UR - https://doi.org/10.1136/bmj.b1665 DO - 10.1136/bmj.b1665 ID - Law2009 ER - TY - JOUR AU - Lee, Y. J. AU - Park, H. H. AU - Koh, S. H. AU - Choi, N. Y. AU - Lee, K. Y. PY - 2011 DA - 2011// TI - Amlodipine besylate and amlodipine camsylate prevent cortical neuronal cell death induced by oxidative stress JO - J Neurochem VL - 119 UR - https://doi.org/10.1111/j.1471-4159.2011.07529.x DO - 10.1111/j.1471-4159.2011.07529.x ID - Lee2011 ER - TY - STD TI - Watfa G, Rossignol P, Kearney-Schwartz A, Fay R, Felblinger J, Boivin JM, Lacolley P, Zannad F, Benetos A. Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. J Hypertens. 2010;12:2485–93. ID - ref16 ER - TY - STD TI - Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, Barkhof F, van der Flier W, Schmidt R, Fazekas F, Scheltens P, Waldemar G, Salvadori E, Pantoni L, Inzitari D, Erkinjuntti T, LADIS Study Group. Comparison of the Alzheimer’s Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study. Dement Geriatr Cogn Disord. 2007;24:73–81. ID - ref17 ER - TY - JOUR AU - Molloy, D. W. AU - Standish, T. I. PY - 1997 DA - 1997// TI - A guide to the standardised Mini-Mental State Examination JO - Int Psychogeriatr VL - 9 UR - https://doi.org/10.1017/S1041610297004754 DO - 10.1017/S1041610297004754 ID - Molloy1997 ER - TY - STD TI - Reitan RM. Trail Making Test: Manual for the Administration and Scoring of the Trail Making Test. Bloomington: Indiana University; 1959. ID - ref19 ER - TY - JOUR AU - Jager, C. A. AU - Budge, M. M. AU - Clarke, R. PY - 2003 DA - 2003// TI - Utility of TICS-M for the assessment of cognitive function in older adults JO - Int J Geriatr Psychiatry VL - 18 UR - https://doi.org/10.1002/gps.830 DO - 10.1002/gps.830 ID - Jager2003 ER - TY - STD TI - Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians’ global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S124–38. ID - ref21 ER - TY - JOUR PY - 1990 DA - 1990// TI - EuroQoL – a new facility for the measurement of health-related quality of life JO - Policy VL - 16 ID - ref22 ER - TY - STD TI - Smith SC, Lamping DL, Banerjee S, Harwood R, Foley B, Smith P, Cook JC, Murray J, Prince M, Levin E, Mann A, Knapp M. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess. 2005;9:1–93. ID - ref23 ER - TY - JOUR AU - Gélinas, I. AU - Gauthier, L. AU - McIntyre, M. AU - Gauthier, S. PY - 1999 DA - 1999// TI - Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia JO - Am J Occup Ther VL - 53 UR - https://doi.org/10.5014/ajot.53.5.471 DO - 10.5014/ajot.53.5.471 ID - Gélinas1999 ER - TY - JOUR AU - Cummings, J. L. AU - Mega, M. AU - Gray, K. AU - Rosenberg-Thompson, S. AU - Carusi, D. A. AU - Gornbein, J. PY - 1994 DA - 1994// TI - The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia JO - Neurology VL - 44 UR - https://doi.org/10.1212/WNL.44.12.2308 DO - 10.1212/WNL.44.12.2308 ID - Cummings1994 ER - TY - STD TI - Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gueje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27:191–7. ID - ref26 ER - TY - STD TI - Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, editor. Measuring Mental Health Needs. 2nd ed. London: Gaskell; 2001. p. 200–24. ID - ref27 ER - TY - STD TI - American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000. ID - ref28 ER - TY - STD TI - Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transmission. 2000;59:23–30. ID - ref29 ER - TY - STD TI - Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P. European Task Force on age-related white matter changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318–22. ID - ref30 ER - TY - STD TI - Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683–9. ID - ref31 ER - TY - STD TI - Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge RV, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. STandards for ReportIng Vascular changes on Euroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38. ID - ref32 ER - TY - JOUR AU - Barkhof, F. PY - 2003 DA - 2003// TI - Guidelines for brain imaging in vascular dementia clinical trials JO - Int Psychogeriatr VL - 1 UR - https://doi.org/10.1017/S1041610203009323 DO - 10.1017/S1041610203009323 ID - Barkhof2003 ER - TY - JOUR AU - Marques, E. AU - Johnson, E. C. AU - Gooberman-Hill, R. AU - Blom, A. W. AU - Noble, S. PY - 2013 DA - 2013// TI - Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials JO - Value Health. VL - 16 UR - https://doi.org/10.1016/j.jval.2012.09.008 DO - 10.1016/j.jval.2012.09.008 ID - Marques2013 ER - TY - STD TI - Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol. 2008;7:310–8. ID - ref35 ER - TY - JOUR AU - Schulz, K. F. AU - Altman, D. G. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c332 DO - 10.1136/bmj.c332 ID - Schulz2010 ER - TY - STD TI - Rowen D, Mulhern B, Banerjee S, Hout B, Young TA, Knapp M, Smith SC, Lamping DL, Brazier JE. Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health. 2012;15:346–56. ID - ref37 ER - TY - STD TI - Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. York: University of York; 1995. ID - ref38 ER -